Condizione: New.
Condizione: New.
Condizione: New.
Condizione: As New. Unread book in perfect condition.
Condizione: New. pp. 72.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 61,78
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 61,77
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 61,38
Quantità: 10 disponibili
Aggiungi al carrelloPF. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 63,71
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 75,23
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 61 pages. 9.25x6.25x0.20 inches. In Stock.
Editore: Springer New York, Springer US Okt 2011, 2011
ISBN 10: 1461416612 ISBN 13: 9781461416616
Lingua: Inglese
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 53,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware -This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 72 pp. Englisch.
Editore: Springer New York, Springer US, 2011
ISBN 10: 1461416612 ISBN 13: 9781461416616
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 56,98
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
EUR 50,10
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Key Statistical Concepts in Clinical Trials for Pharma | J. Rick Turner | Taschenbuch | ix | Englisch | 2011 | Springer US | EAN 9781461416616 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 39,79
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Gut. Zustand: Gut | Sprache: Englisch | Produktart: Bücher.
Editore: Springer New York Okt 2011, 2011
ISBN 10: 1461416612 ISBN 13: 9781461416616
Lingua: Inglese
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 53,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance. 72 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 75,67
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 72 Illus.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 77,66
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 72.
Da: moluna, Greven, Germania
EUR 48,37
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. J. Rick Turner, PhD, is an experimental research scientist and clinical trialist, and currently Senior Scientific Director, Integrated Cardiovascular Safety, Quintiles. With his colleagues, he provides Sponsors with consultation, strategic and regulatory in.